Fair Value Calculator Fair Value Calculator
EN DE

0509 (0509) Fair Value & Analysis

Basic Materials · Market cap HK$19.5M

0 0509 0509 · HK
PriceHK$0.1700
Fair ValueHK$0.1505
Upside-11.5%
Quality47/100
Evidence: Low Range HK$0.1122 – HK$0.2246

Fair value as of: Jul 2, 2026

From 1 valuation models · updated today

Price vs Fair Value (12 months)

HK$0.1700 HK$0.1700 Fair Value HK$0.1505 Jun 2025 Jun 2026

12‑month range HK$0.1700 – HK$0.1700 · fair‑value band HK$0.1122 – HK$0.2246 · the HK$0.1700 price screens above the HK$0.1505 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0509 (0509) currently trades at HK$0.1700, while our model-based Fair Value estimate is HK$0.1505 — implying the stock looks roughly 11.5% overvalued today. We read business quality at 47/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 0509 generated revenue of HK$330M at a net margin of -27.6%. Revenue grew 11.4% year over year. It earns a return on equity of -53.8%. Net debt stands at HK$1.6B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$330M
Revenue growth (YoY) +11.4%
Net margin -27.6%
Return on equity -53.8%
Free cash flow −HK$39.0M FY2023
Operating margin -56.6%
More key figures
EPS growth (YoY) +17.7%
Net debt HK$1.6B FY2023

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2019 – FY2023 · reported fiscal years

0509 reported revenue of HK$316M in FY2023 versus HK$4.3B in FY2019, a compound −48.0%/yr. Reported net income was −HK$237M in FY2023.

Revenue −48.0%/yr
FY19 HK$4.3B
FY20 HK$2.2B
FY21 HK$1.3B
FY22 HK$532M
FY23 HK$316M
Net income
FY19 HK$380M
FY20 −HK$745M
FY21 −HK$1.1B
FY22 −HK$1.0B
FY23 −HK$237M

Is 0509 fairly valued? → Check now

Similar stocks

6 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
Corteva, Inc CTVA $77.46 $39.29 -49%
Nutrien Ltd NTR $65.03 $50.33 -23%
Qinghai Salt Lake Industry Co 000792 ¥30.69 ¥26.81 -13%
CF Industries Holdings C1FI34 R$577.43 R$978.53 +69%
Yara International ASA YAR kr 502.80 kr 695.65 +38%
ICL Group ICL $6.21 $3.02 -51%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 0509 (0509) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.1505 versus a price of HK$0.1700 — about −11% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 0509?
Our model-based fair value for 0509 is HK$0.1505 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.1700.
What is the quality score of 0509?
0509 has a Quality Score of 47/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 0509 (0509)?
0509 reported trailing-twelve-month revenue of about HK$330M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 0509?
The net profit margin of 0509 is about -27.6%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.